Ergoteles LLC Instil Bio, Inc. Transaction History

Ergoteles LLC

  • $68.2 Billion
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023
BUY
$0.6 - $0.91 $1,127 - $1,709
1,879 Added 5.01%
39,383 $25,000
Q4 2022

Feb 14, 2023
BUY
$0.48 - $5.33 $18,001 - $199,896
37,504 New
37,504 $23,000
Q4 2021

Feb 14, 2022
SELL
$15.37 - $22.5 $1.23 Million - $1.8 Million
-79,911 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$15.05 - $23.28 $1.2 Million - $1.86 Million
79,911 New
79,911 $1.43 Million

Others Institutions Holding TIL

# of Institutions
2
Shares Held
1.9M
Call Options Held
0
Put Options Held
0
View Full List

About Instil Bio, Inc.

TIL Quotes by TradingView
  • Ticker TIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,694,000
  • Market Cap $2.82B
  • Description
  • Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...
More about TIL
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email